Keyphrases
Non-small Cell Lung Cancer Patients
100%
Cellular Level
50%
Immune Checkpoint Blockade
50%
African American
50%
Tumor
50%
Immune Tumor Microenvironment
37%
Non-small Cell Lung Cancer (NSCLC)
25%
Baptists
18%
Caucasian American
18%
Comprehensive Cancer Center
18%
Lung Cancer
18%
Single-cell RNA Sequencing (scRNA-seq)
18%
Cancer Disparities
18%
Generating Hypothesis
12%
Immunosuppressive Microenvironment
12%
Lung Cancer Patients
12%
Clinical Association
12%
Specific Intent
12%
Mutation Profiling
12%
Mutational Patterns
12%
African American Patients
12%
Immune Landscape
12%
Cancer Health Equity
12%
American Sample
12%
Tumor Cell Microenvironment
12%
Underserved Patient Population
12%
Tumor mutation Burden
12%
Mutational Event
12%
Tumor Microenvironment
12%
Targeted Therapeutics
6%
Cancer Population
6%
Immune Regulation
6%
Association Study
6%
Cancer Patients
6%
Large Cohort
6%
Racial Health Disparities
6%
Cancer Research
6%
Sequence Method
6%
Genetic mutation
6%
Health Disparities
6%
Racial Groups
6%
TP53 mutation
6%
Mortality Rate
6%
Mutation Rate
6%
Tumor Cells
6%
Cancer Diagnosis
6%
Incidence Rate
6%
Cancer Incidence
6%
Drug Treatment
6%
Patient Samples
6%
Clinical Observation
6%
Somatic mutation
6%
Biochemistry, Genetics and Molecular Biology
Cell Level
100%
Immune Checkpoints
100%
RNA Sequence
75%
Health Disparity
75%
Immunoregulation
25%
Mutation Rate
25%
Gene Mutation
25%
Mortality Rate
25%
Somatic Mutation
25%
Medicine and Dentistry
Immune Checkpoint Blockade
57%
Non Small Cell Lung Cancer
50%
Neoplasm
50%
Malignant Neoplasm
50%
Lung Cancer
28%
Tumor Microenvironment
21%
RNA Sequence
21%
Tumor Immune Microenvironment
21%
Health Disparity
14%
Tumor Cell
14%
Tumor Mutation Burden
14%
Mutation Rate
14%
Immunotherapy
7%
Mortality Rate
7%
Gene Mutation
7%
Patient Population
7%
Racial Health Disparity
7%
Racial Group
7%
Immunoregulation
7%
Drug Therapy
7%
Clinical Observation
7%
Cancer Research
7%
Cancer Diagnosis
7%
Immunosuppressive Drug
7%
Somatic Mutation
7%